Diabetes Research and Clinical Practice
Volume 90, Issue 2 , Pages e25-e26, November 2010

Angiotensin converting enzyme inhibitor or angiotensin II receptor blocker for the prevention of type 2 diabetes mellitus?

  • Ching-Chu Chen

      Affiliations

    • Division of Endocrinology and Metabolism, Department of Medicine, China Medical University Hospital, Taichung, Taiwan
    • School of Chinese Medicine, College of Chinese Medicine, China Medical University, Taichung, Taiwan
    • Corresponding Author InformationCorresponding author at: Division of Endocrinology and Metabolism, Department of Medicine, China Medical University Hospital, No. 2, Yuh-Der Road, Taichung 40447, Taiwan. Tel.: +886 4 22062121x3489; fax: +886 4 22038883.

Institute of Biochemistry and Molecular Biology, National Yang-Ming University, Taipei, Taiwan

Division of Endocrinology and Metabolism, Department of Medicine, China Medical University Hospital, Taichung, Taiwan

Received 8 January 2010 published online 01 July 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0168-8227(10)00277-9

doi:10.1016/j.diabres.2010.05.028

Diabetes Research and Clinical Practice
Volume 90, Issue 2 , Pages e25-e26, November 2010

Article Tools

* Image Usage & Resolution